12/5/2023 0 Comments Healthier together medtronicThe AdaptivCRT algorithm adjusts therapy according to minute-by-minute evaluations of a patient’s heart rhythm and has been shown to reduce the likelihood of 30-day heart failure hospital readmissions, reduce the risk of atrial fibrillation, and improve patient survival. Spectrum Health will work with Medtronic on a program designed to automate the identification of readmission events in patients who receive a Medtronic Cardiac Resynchronization Therapy device with the AdaptivCRT™ algorithm under an existing financial accountability program. The first program will be designed around Cardiac Resynchronization Therapy for patients with heart failure and electrical dyssynchrony – a condition that can cause the lower chambers of the heart to beat out of sync, forcing the heart to work harder. “Now, more than ever, in an era when health systems are dealing with the impact of COVID-19, prioritizing value-based healthcare enables us to optimize where care is provided, create cost efficiencies, and drive variability out of operations to bring the highest quality care to our patients at the lowest cost.” “The agreement with Medtronic aligns with Spectrum Health’s vision of personalized health made simple, affordable, and exceptional,” said Darryl Elmouchi, M.D., president, Spectrum Health West Michigan. Together, the organizations will use data and near real-time analytics to design programs intended to help standardize care, reduce clinical variation, and deliver greater personalization of care by applying the right medical technologies and therapies to patients who may benefit most. Through its collaboration with Medtronic, Spectrum Health will work to develop and deploy value-based healthcare programs designed to address health conditions impacting patients and communities in West Michigan. Spectrum Health’s collaboration with Medtronic is an integral component of Spectrum Health’s focus on vendor partnerships that improve quality of care, reduce costs, and ultimately drive value for patients and communities. The two organizations will explore the creation of value-based healthcare programs to support the evidence-based adoption and appropriate use of medical technologies and therapies at Spectrum Health. and DUBLIN – March 31, 2021– Spectrum Health and Medtronic plc (NYSE:MDT) have entered into an agreement with the goal of driving value in healthcare and improving outcomes for Spectrum Health patients, while reducing the cost of care.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |